2021
DOI: 10.12688/wellcomeopenres.16474.2
|View full text |Cite
|
Sign up to set email alerts
|

Host Directed Therapies for Tuberculous Meningitis

Abstract: A dysregulated host immune response significantly contributes to morbidity and mortality in tuberculous meningitis (TBM). Effective host directed therapies (HDTs) are critical to improve survival and clinical outcomes. Currently only one HDT, dexamethasone, is proven to improve mortality. However, there is no evidence dexamethasone reduces morbidity, how it reduces mortality is uncertain, and it has no proven benefit in HIV co-infected individuals. Further research on these aspects of its use, as well as alter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 119 publications
(186 reference statements)
0
6
0
1
Order By: Relevance
“…Uncertainty surrounds the mechanism by which corticosteroids offer clinical benefit, but it is possible due to a diminution in intracerebral inflammation. 20 This report describes a fatal case of tuberculous meningitis. Tuberculous meningitis is the most devastating form of extrapulmonary tuberculosis if left untreated.…”
Section: Discussionmentioning
confidence: 98%
“…Uncertainty surrounds the mechanism by which corticosteroids offer clinical benefit, but it is possible due to a diminution in intracerebral inflammation. 20 This report describes a fatal case of tuberculous meningitis. Tuberculous meningitis is the most devastating form of extrapulmonary tuberculosis if left untreated.…”
Section: Discussionmentioning
confidence: 98%
“…Post-TBM sequelae are mostly due to a dysregulated host immune response. 235 , 236 Therefore, host-directed therapies are the most promising strategy to improve overall survival and long-term clinical outcomes. More data are needed to inform the treatment of childhood TBM.…”
Section: Children and Adolescents Post-tb Diseasementioning
confidence: 99%
“…The interventions tested include higher doses of rifampicin (15-35mg/kg) [3], adding anti-tuberculosis drugs with good brain penetration (e.g. fluoroquinolones, linezolid) [4], or controlling brain inflammation with adjunctive corticosteroids and aspirin [5].…”
Section: Textmentioning
confidence: 99%